BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
BioAdaptives (OTC: BDPT) launched MyndRenew on May 6, 2026, a nighttime dietary supplement aimed at supporting sleep quality and the brain's overnight recovery processes as part of the MyndSystem platform.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioAdaptives (OTC: BDPT) launched MyndRenew on May 6, 2026, a nighttime dietary supplement aimed at supporting sleep quality and the brain's overnight recovery processes as part of the MyndSystem platform.
MyndRenew contains 13 ingredients at research-consistent levels, including magnesium glycinate, apigenin, PEA, and lion's mane extract, and is available now at www.myndsystem.com.
Details
News Market Reaction – BDPT
On May 6, the day this news came out, BDPT closed 34.74% above the previous close.
Data tracked by StockTitan Argus for the May 6 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep
LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) -- via IBN — More than 1 in 3 American adults report insufficient sleep — a deficit that research increasingly links to measurable declines in next-day cognitive performance. Yet the supplement industry has focused almost exclusively on the waking hours, leaving the brain's critical overnight recovery window largely unaddressed.
BioAdaptives, Inc. (OTC: BDPT) today announced the launch of MyndRenew™, a nighttime dietary supplement formulated to support sleep quality and the brain's natural overnight recovery processes. MyndRenew™ is the nighttime component of the Company's MyndSystem™ platform — a first-of-its-kind approach to cognitive support that spans the full 24-hour cycle.
Addressing the Overlooked Half of Cognitive Health
While the market has been saturated with morning stacks and daytime nootropics, the physiological processes that unfold during sleep — cellular repair, memory consolidation, metabolic waste clearance — have received comparatively little attention from supplement developers. MyndRenew™ was built to change that.
The formulation features 13 ingredients selected from published scientific literature, each included at levels consistent with those evaluated in clinical research. Together, they are intended to support multiple aspects of nighttime physiology:
- Sleep quality and relaxation pathways
- The brain's natural overnight maintenance and recovery processes
- Cellular resilience and mitochondrial energy function
- Stress response regulation and nervous system balance
- Antioxidant and neuroprotective activity
Key ingredients include magnesium glycinate, apigenin, PEA, and lion's mane mushroom extract — anchor compounds with established research profiles in sleep quality, stress resilience, and neuroprotection, respectively.
Management Commentary
"We kept hearing from people who were doing everything right during the day — good nutrition, the right supplements, focused work habits — and still feeling mentally sluggish. The answer was often what wasn't being supported at night. MyndRenew™ was built to close that gap."
— James Keener, Chief Executive Officer, BioAdaptives, Inc.
The MyndSystem™ Platform: Full-Cycle Cognitive Support
MyndRenew™ joins MyndMed™ as the second pillar of the MyndSystem™ platform, which is designed to align with the brain's distinct demands across the full daily cycle:
- MyndMed™ — Daytime formulation designed to support focus, mental clarity, and cognitive endurance during waking hours
- MyndRenew™ — Nighttime formulation designed to support sleep quality and the brain's overnight recovery processes
Availability
MyndRenew™ is available now at www.myndsystem.com, alongside MyndMed™ and complete MyndSystem™ information. The Company also provides updates via X (formerly Twitter) at @BioAdaptivesInc.
About BioAdaptives, Inc.
BioAdaptives, Inc. develops and markets science-based health and wellness products for human and animal use. Its formulations are rooted in published research across nutrition, adaptogens, and cellular health, with a focus on supporting normal physiological function.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding product positioning, expected benefits, market opportunity, and future business strategy. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. BioAdaptives undertakes no obligation to update these statements except as required by law.
INVESTOR & MEDIA CONTACT
Emily Harrison
Investor Relations, BioAdaptives, Inc.
(702) 703-1233 | info@bioadaptives.com | www.bioadaptives.com
X – @BioAdaptivesInc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.